Found: 6
Select item for more details and to access through your institution.
Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241293951
- By:
- Publication type:
- Article
Recurrent Glioblastoma: A Review of the Treatment Options.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4279, doi. 10.3390/cancers15174279
- By:
- Publication type:
- Article
A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 792, doi. 10.3390/cancers13040792
- By:
- Publication type:
- Article
A DNA damage repair gene‐associated signature predicts responses of patients with advanced soft‐tissue sarcoma to treatment with trabectedin.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 12, p. 3691, doi. 10.1002/1878-0261.12996
- By:
- Publication type:
- Article
SEOM-GEINO clinical guidelines for grade 2 gliomas (2023).
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 11, p. 2856, doi. 10.1007/s12094-024-03456-x
- By:
- Publication type:
- Article
Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO).
- Published in:
- Targeted Oncology, 2020, v. 15, n. 5, p. 613, doi. 10.1007/s11523-020-00754-6
- By:
- Publication type:
- Article